Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Diabetes Mellitus: full-pipeline trial registry
49 of 210 indexed Diabetes Mellitus trials are currently recruiting.
Corpus placement: #44 of 28,707 conditions by registered trial count.
210 US clinical trials · 49 currently recruiting · #44 of 28,707 conditions by registered trial count
Diabetes Mellitus: 210 US clinical trials tracked, 49 recruiting.
Diabetes Mellitus is the subject of 210 registered US clinical trials on ClinicalTrials.gov, 49 of them currently open to new participants. 26 are in Phase 3-4 (later-stage) and 32 in Phase 1-2 (earlier-stage). The most active sponsor is Takeda, running 8 of these trials.
Enrollment posture brief
Registry condition diabetes-mellitus
OPEN 49 | RECR 23% | LATE 26 | EARLY 32 | RANK #44 | SPON 8
Volume-matched condition peers
Nearest open-share peer: Alzheimers Disease (23% recruiting · 150 trials)
Diabetes Mellitus lists 49 open slots (23% of 210 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Diabetes Mellitus on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Diabetes Mellitus is recruiting below its size-band peers.
49 of 210 indexed trials (23.3%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Diabetes Mellitus trials is spread across many organizations.
Takeda accounts for 8 of 210 trials (3.8%). 123 distinct sponsors appear on at least one study for this condition label.
-
Typical Diabetes Mellitus enrolment sits around 136 participants.
Median target enrolment is 136 among the 209 trials that report a genuine target (sentinel values excluded). 86 of those (41.1%) plan for fewer than 100 participants.
-
Diabetes Mellitus research is mostly interventional.
175 interventional and 35 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
210 total, page 5 of 5
Iron Depletion Therapy for Type 2 DM and NAFLD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00230087
A Study to Evaluate the Safety of THR-687 in Subjects With Diabetic Macular Edema (DME)
ThromboGenics
NCT03666923
Multiple Dose Safety Toelrability, Pharmacokinetics and Midazolam Interaction In Healthy Overweight And Obese Subjects
Pfizer
NCT01757756
A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)
ThromboGenics
NCT03511898
Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 Diabetes
University of New Mexi
NCT00659165
Impact of Empagliflozin on Functional Capacity in Heart Failure with Preserved Ejection Fraction
University of Texas Southwestern Medical Center
NCT05139472
Cryovagotomy Diabetes Trial
Emory University
NCT04276051
OT-Led Interdisciplinary Diabetes Self-Management Prgm
Arizona State University
NCT03821662
Peak Plantar Pressures While Wearing a Carbon Fiber Off Loading Orthoses
Washington University School of Medicine
NCT03618628
Aging and Cellular Mechanism for Insulin Action After Exercise Training
US Department of Veterans Affairs
NCT00018239
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 13 |
| Phase 2 | 19 |
| Phase 3 | 18 |
| Phase 4 | 8 |
Top Sponsors
Named interventions
Most-linked intervention names on Diabetes Mellitus records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Diabetes Mellitus trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Diabetes Mellitus page
210 registered trials, 49 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 49 Diabetes Mellitus trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Takeda sponsors the most Diabetes Mellitus trials on record, review their full trial history before evaluating a specific study. See Takeda's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diabetes Mellitus condition card totals 210 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.